Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa

In order to evaluate the serum anti-skin autoantibodies and cytokine concentrations in patients with different epidermolysis bullosa (EB) types and severity, 42 EB patients and 38 controls were enrolled. Serum anti-skin antibodies were significantly higher in the patients than in the controls (p = 0...

Full description

Bibliographic Details
Main Authors: Susanna Esposito, Sophie Guez, Annalisa Orenti, Gianluca Tadini, Giulietta Scuvera, Laura Corti, Alessia Scala, Elia Biganzoli, Emilio Berti, Nicola Principi
Format: Article
Language:English
Published: MDPI AG 2016-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/17/10/1625
_version_ 1811239698275762176
author Susanna Esposito
Sophie Guez
Annalisa Orenti
Gianluca Tadini
Giulietta Scuvera
Laura Corti
Alessia Scala
Elia Biganzoli
Emilio Berti
Nicola Principi
author_facet Susanna Esposito
Sophie Guez
Annalisa Orenti
Gianluca Tadini
Giulietta Scuvera
Laura Corti
Alessia Scala
Elia Biganzoli
Emilio Berti
Nicola Principi
author_sort Susanna Esposito
collection DOAJ
description In order to evaluate the serum anti-skin autoantibodies and cytokine concentrations in patients with different epidermolysis bullosa (EB) types and severity, 42 EB patients and 38 controls were enrolled. Serum anti-skin antibodies were significantly higher in the patients than in the controls (p = 0.008, p < 0.001, p < 0.001, p < 0.001 and p < 0.001 for desmoglein 1 (DSG1) desmoglein 3 (DSG3), bullous pemphigoid 180 (BP180), BP230 and type VII collagen (COL7), respectively). The same trend was observed for interleukin (IL)-1β, IL-2, IL-6, IL-10, tumor necrosis factor-β, and interferon-γ (p < 0.001, p < 0.001, p < 0.001, p = 0.008, p < 0.001 and p = 0.002, respectively). Increases in anti-skin antibodies and cytokine concentrations were higher in patients with recessive dystrophic EB than in those with different types of EB, in generalized cases than in localized ones, and in patients with higher Birmingham Epidermolysis Bullosa Severity (BEBS) scores than in those with a lower score. The BEBS score was directly correlated with BP180, BP230, COL7 (p = 0.015, p = 0.008 and p < 0.001, respectively) and IL-6 (p = 0.03), whereas IL-6 appeared significantly associated with DSG1, DSG3, BP180, BP230 and COL7 (p = 0.015, p = 0.023, p = 0.023, p = 0.015 and p = 0.005, respectively). This study showed that autoimmunity and inflammatory responses are frequently activated in EB, mainly in severe forms, suggesting the use of immunosuppressive drugs or biologicals that are active against pro-inflammatory cytokines to reduce clinical signs and symptoms of disease.
first_indexed 2024-04-12T13:05:42Z
format Article
id doaj.art-348e800ce90d46e7b0842708ae3fd168
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-12T13:05:42Z
publishDate 2016-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-348e800ce90d46e7b0842708ae3fd1682022-12-22T03:32:02ZengMDPI AGInternational Journal of Molecular Sciences1422-00672016-09-011710162510.3390/ijms17101625ijms17101625Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis BullosaSusanna Esposito0Sophie Guez1Annalisa Orenti2Gianluca Tadini3Giulietta Scuvera4Laura Corti5Alessia Scala6Elia Biganzoli7Emilio Berti8Nicola Principi9Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyPediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyPediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyPediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyPediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyDermatology Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyPediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyUnit of Medical Statistics, Biometry and Bioinformatics “G.A. Maccacaro”, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan 20122, ItalyDermatology Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyPediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, ItalyIn order to evaluate the serum anti-skin autoantibodies and cytokine concentrations in patients with different epidermolysis bullosa (EB) types and severity, 42 EB patients and 38 controls were enrolled. Serum anti-skin antibodies were significantly higher in the patients than in the controls (p = 0.008, p < 0.001, p < 0.001, p < 0.001 and p < 0.001 for desmoglein 1 (DSG1) desmoglein 3 (DSG3), bullous pemphigoid 180 (BP180), BP230 and type VII collagen (COL7), respectively). The same trend was observed for interleukin (IL)-1β, IL-2, IL-6, IL-10, tumor necrosis factor-β, and interferon-γ (p < 0.001, p < 0.001, p < 0.001, p = 0.008, p < 0.001 and p = 0.002, respectively). Increases in anti-skin antibodies and cytokine concentrations were higher in patients with recessive dystrophic EB than in those with different types of EB, in generalized cases than in localized ones, and in patients with higher Birmingham Epidermolysis Bullosa Severity (BEBS) scores than in those with a lower score. The BEBS score was directly correlated with BP180, BP230, COL7 (p = 0.015, p = 0.008 and p < 0.001, respectively) and IL-6 (p = 0.03), whereas IL-6 appeared significantly associated with DSG1, DSG3, BP180, BP230 and COL7 (p = 0.015, p = 0.023, p = 0.023, p = 0.015 and p = 0.005, respectively). This study showed that autoimmunity and inflammatory responses are frequently activated in EB, mainly in severe forms, suggesting the use of immunosuppressive drugs or biologicals that are active against pro-inflammatory cytokines to reduce clinical signs and symptoms of disease.http://www.mdpi.com/1422-0067/17/10/1625autoimmunityBirmingham Epidermolysis Bullosa Severity (BEBS) scoreepidermolysis bullosainflammatory responseinherited epidermolysis bullosa
spellingShingle Susanna Esposito
Sophie Guez
Annalisa Orenti
Gianluca Tadini
Giulietta Scuvera
Laura Corti
Alessia Scala
Elia Biganzoli
Emilio Berti
Nicola Principi
Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa
International Journal of Molecular Sciences
autoimmunity
Birmingham Epidermolysis Bullosa Severity (BEBS) score
epidermolysis bullosa
inflammatory response
inherited epidermolysis bullosa
title Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa
title_full Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa
title_fullStr Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa
title_full_unstemmed Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa
title_short Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa
title_sort autoimmunity and cytokine imbalance in inherited epidermolysis bullosa
topic autoimmunity
Birmingham Epidermolysis Bullosa Severity (BEBS) score
epidermolysis bullosa
inflammatory response
inherited epidermolysis bullosa
url http://www.mdpi.com/1422-0067/17/10/1625
work_keys_str_mv AT susannaesposito autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT sophieguez autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT annalisaorenti autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT gianlucatadini autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT giuliettascuvera autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT lauracorti autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT alessiascala autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT eliabiganzoli autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT emilioberti autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa
AT nicolaprincipi autoimmunityandcytokineimbalanceininheritedepidermolysisbullosa